US Patent 11352403 Activatable interleukin-2 polypeptides and methods of use thereof
Patent 11352403 was granted and assigned to Werewolf Therapeutics on June, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
May 21, 2020
0
Date of Patent
June 7, 2022
0
Patent Applicant
Patent Application Number
16880606
0
Patent Citations
Patent Inventor Names
William Winston
0
Heather Brodkin
0
Jose Andres Salmeron Garcia
0
Luke Evnin
0
Patrick Baeuerle
0
Vinay Bhaskar
0
Cynthia Seidel-Dugan
0
Daniel Hicklin
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11352403 Activatable interleukin-2 polypeptides and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
